Prospective observational study of Carbon ion radiotherapy for solitary fibrous tumor

Prospective observational study of Carbon ion radiotherapy for solitary fibrous tumor - Prospective observational study of Carbon ion radiotherapy for solitary fibrous tumor

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048444

Enrollment

Registered

2022-07-25

Start date

2022-07-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solitary fibrous tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient has a confirmed histological diagnosis of a solitary fibrous tumor. The tumor is unresectable. Performance status (ECOG) is 0 to 2. Expected to survive more than 12 months. Written consent for participation in this study will be obtained from the candidate. Carbon ion radiotherapy will be performed in accordance with the protocol of the Japanese Society for Radiation Oncology.

Exclusion criteria

Exclusion criteria: Diagnosed with malignant solitary fibrous tumor. The patient has a severe complication that is intolerable to treatment. Concurrent systemic therapy (chemotherapy, molecular-targeted therapy, or immunotherapy) is administered during irradiation. Active and refractory infection at the irradiated site. Clinical, psychological, or other factors that the physician in charge considers inappropriate.

Design outcomes

Primary

Measure	Time frame
local control rate and overall survival rate	—

Countries

Japan

Contacts

Public ContactReiko Imai

National Institutes for Quantum Science and Technology QST Hospital

imai.reiko@qst.go.jp0432063306

Outcome results